Tvardi Therapeutics TVRD
NASDAQ TVRD
$0.97 -0.05 (-4.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Other Investing Activities (2016)

Updated

Analysis

Tvardi Therapeutics (TVRD) Other Investing Activities (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,147.74 Bn 1,116.33 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 636.22 Bn 556.08 Bn 17.30 Bn 352.00 Mn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -51.00 Mn
4 Merck 357.93 Bn 312.30 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 301.67 Bn 265.66 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 264.02 Bn 237.70 Bn 12.86 Bn 174.00 Mn
7 Amgen 239.31 Bn 194.70 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 194.97 Bn 169.17 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn -1.00 Mn
10 Tvardi Therapeutics 9.29 Mn -98.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 -769,000.00
API Access

Tvardi Therapeutics Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=TVRD&period=max&api_key=YOUR_API_KEY